NCF International

The 2026–2028 Workplan of the European Medicines Agency’s Quality Innovation Group (QIG) outlines a strategic roadmap that is set to shape the future of pharmaceutical manufacturing, quality control, and regulatory science across Europe

COMPASS-AI is the name of the new European Commission initiative that aims to establish a community of experts to promote the safe and effective use of artificial intelligence (AI) in the healthcare sector

AI is increasingly reshaping the pharmaceutical industry, moving beyond experimental use cases to become a concrete component of regulatory decision-making and patient-facing processes. Its growing adoption is redefining how medicinal products are researched, developed, approved and monitored throughout their lifecycle

As part of a broader package of bilateral agreements negotiated between the EU and the Swiss Confederation in 2024, Switzerland will join several R&I Union programmes, including Horizon Europe, Digital Europe, and EU4Health